Authors: Sergei Chavez Abiega, Saskia de Man, Tomas Veenendaal, Michelle Kop, Valeria Teodosieva, Jarmil Hanrath, Virgil Woerdings, Emma Spanjaard, Marrit Putker, Gera Goverse
![]()
Bispecific antibodies are rapidly emerging as powerful immunotherapies, but evaluating their activity in physiologically relevant models remains a challenge. At Crown Bioscience, we have developed a high-content, image-based screening platform to study the complex interactions between immune cells and 3D patient-derived organoids (PDOs).
This poster showcases how our platform captures and quantifies immune cell activation, infiltration, migration, and organoid killing in response to bispecific antibodies targeting Claudin 18.2 and EGFR across multiple tumor types and ex vivo patient samples.
Explore the full dataset, figures, and methodology behind our high-content organoid co-culture platform.
Your privacy is important to us.
We'll never share your information.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy
2025-10-02
2025-09-10
landing_page
In Vitro: Amplify Organoids